Symptom-centric view
Injection site injury
Substances reporting Injection site injury disproportionately — ranked by ROR.
showing 1 of 1
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tirzepatide Mounjaro · Zepbound | 52.4 [49.2–55.7] | 1,381 | glp-1 | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).